Abstract
In recent years there have been dramatic advances in all the imaging specialities, with growth of the use of ultrasound and computed tomography (CT) scanning and the introduction of magnetic resonance imaging (MRI). An integrated imaging approach to a specific problem is required for optimal results and the use of these newer modalities is discussed elsewhere in this book. Nevertheless, despite these changes the radionuclide bone scan remains unchallenged in its role of investigating skeletal pathology, because of its exquisite sensitivity for lesion detection and its ability rapidly to evaluate the whole skeleton. In contrast to routine radiology, sites such as ribs, sternum and scapula are clearly seen. The early experience of bone scanning was almost exclusively in patients with known malignancy and, while the role of bone scanning has now expanded to many benign situations, the identification of metastases still remains the most important indication for a bone scan. In this review we shall attempt to define the role of bone scanning in the detection and monitoring of skeletal metastases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alexander JL, Gillespie PJ, Edelstyn GA (1982) Serial bone scanning using technetium 99m diphosphonate in patients undergoing cyclical combination chemotherapy for advanced breast cancer. Clin Nucl Med 7:397–402
Antoniades J, Croll MN, Walner RJ, Brady LW, McKhann CB (1976) Bone scanning in carcinoma of the colon and rectum. Dis Colon Rectum 19:139–143
Aranha GV, Simmons RL, Gunnarsson A, Grage TB (1979) The value of preoperative screening procedures in stage I and II malignant melanoma. J Surg Oncol 11:1–6
Au FC, Maier WP, Malmud LS, Goldman LI, Clark WH (1984) Preoperative nuclear scans in patients with melanoma. Cancer 53:2095–2097
Babaian RJ, Johnson DE, Llamas L, Ayala AG (1980) Metastases from transitional cell carcinoma of urinary bladder. Urology 16:142–144
Baker RR (1978) Preoperative assessment of the patient with breast cancer. Surg Clin North Am 64:1039–1050.
Bassan JS, Glaser MG (1982) Bony metastases in carcinoma of the uterine cervix. Clin Radiol 33:623–625
Beals RK, Lawton GD, Swell WE (1971) Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer 28:1350–1354
Belson TP, Lehman RH, Chobanian DL, Malin TC (1980) Bone and liver scans in patients with head and neck carcinoma. Laryngoscope 90:1291–1296
Berger GL, Sadlowski RW, Sharpe JR, Finney RP (1981) Lack of value of routine preoperative bone and liver scans in cystectomy candidates. J Urol 125:637–639
Biersack HJ, Wegner G, Distelmaier W, Krause U (1980) Ossare Metastasierung des Prostatakerzi-noms in Abhangigkeit von Tumorgrosse und Geschwulstdifferenzienung. Nuklearmedizin 19:29–32
Bishop HM, Blamey RW, Morris AH, Rose DH, Preston B, Lane J, Doyle PJ (1979) Bone scanning: its lack of value in the follow-up of patients with breast cancer. Br J Surg 66:752–754
Bitran LD, Beukerman C, Pinsky S (1981) Sequential scintigraphic staging of small cell carcinoma. Cancer 47:1971–1975
Bourgeois P, Gassavelis C, Malarme M, Feremans W, Fruhling J (1989) Bone marrow scintigraphy in breast cancer. Nucl Med Commun 10:389–400
Brismar J, Gustafson T (1988) Bone scintigraphy in staging of bladder carcinoma. Acta Radiologica 29:251–252
British Breast Group (1978) Bone scanning in breast cancer. Br Med J ii: 180–181
Brown ML (1983) Significance of the solitary lesion in pediatric bone scanning. J Nucl Med 24:114–115
Ciatto S, Pacini P, Bravetti P, Cataliotta L, Cardona G, Crescioli R, Pupi A (1985) Staging breast cancer -screening for occult metastases. Tumori 71:339–344
Citrin DL, Bessent RG, Greig WR (1977) A comparison of the sensitivity and accuracy of the Tc99m phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 28:107–117
Citrin DL, Furnival CM, Bessent RG, Greig WR, Bell G, Blumgart LH (1976) Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary carcinoma of the breast. Surg Gynecol Obstet 143:360–364
Chaudary MA, Maisey MN, Shaw P, Rubens RD, Hayward JL (1983) Sequential bone scanning and chest radiographs in the postoperative management of early breast cancer. Br J Surg 70:517–518
Clyne CAC, Frank JW, Jenkins JD, Smart CJ (1983) The place of 99mTc-polyphosphonate bone scan in renal carcinoma. Br J Urol 55:174–175
Coleman, RE, Habibollahi R, Rubens RD, Fogelman I (1986) Bone scintigraphy in early breast cancer: The relevance of tumour characteristics in identifying patients for serial scanning. Nucl Med Commun 7:292
Coleman, RE, Rubens, RD (1985) Bone metastases and breast cancer. Cancer Treat Rev 12:251–270
Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61–66
Coleman RE, Rubens RD, Fogelman I (1988a) Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 29:1345–1349
Coleman RE, Rubens RD, Fogelman I (1988b) A reappraisal of the baseline bone scan in breast cancer. J Nucl Med 29:1045–1049
Coleman RE, Rubens RD, Meier C, Fogelman I (1987) A clinical comparison of two bone scanning agents in breast cancer (Abstract). Nucl Med Commun 8:245–246
Constable AR, Cranage RW (1981) Recognition of the superscan in prostatic bone scintigraphy. Br J Radiol 54:122–125
Corcoran RJ, Thrall JH, Kyle RW (1976) Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121:663–667
Corrie D, Timmons JH, Bauman JH, Thompson IM (1988) Efficacy of follow-up scans in carcinoma of prostate. Cancer 61:195–202
Daubenton JD, Fisher RM, Karabus CD, Mann MD (1987) The relationship between prognosis and scintigraphic evidence of bone metastases in neuroblastoma. Cancer 59:1586–1589
Davey P, Merrick MV, Duncan W, Padpath AT (1985) Bladder cancer: the value of routine bone scintigraphy. Clin Radiol 36:77–79
Davies CJ, Griffiths PA, Preston BJ, Morris AH, Elston CW, Blamey RW(1977) Staging breast cancer. Role of scanning. Br Med J ii:603– 605
DeGroot LJ, Reilly M (1984) Use of isotope bone scans and skeletal survey x-rays in the follow-up of patients with thyroid carcinoma. J Endocrinol Invest 7:175–179
Donato AT, Ammerman EG, Sullesta O (1979) Bone scanning in the evaluation of the patients with lung cancer. Ann Thorac Surg 27:300–304
Drelichman A, Decker A, Al-Sarraf M, Vaitkevicius VK, Muz J (1984) Computerised bone scan. A potentially useful technique to measure response in prostatic carcinoma. Cancer 53:1061–1065
Du Toit JP, Grove DV (1987) Radio-isotope bone scanning for the detection of occult bony metastases in invasive cervical carcinoma. Gynecol Oncol 28:215–219
Edelstyn GA, Gillespie PJ, Grebell FS (1967) The radiological demonstration of osseus metastases: experimental observations. Clin Radiol 18:158–162
El Domeiri AA, Shroff S (1976) Role of preoperative bone scan in carcinoma of the breast. Surg Gynecol Obstet 142:722–724
Fogelman I (1982) Diphosphonate bone scanning agents -current concepts. Eur J Nucl Med 7:506–509
Fogelman I (1987) Tc99m Bone scanning agents. In: Fogelman I (ed) Bone scanning in clinical practice. Springer-Verlag, London, pp 31–40
Fogelman I, Coleman R (1988) The bone scan in breast cancer. In: Freeman L, Weissman H (eds) Nuclear medicine annual. Raven Press, New York, pp 1–38
Fogelman I, McKillop JH, Greig WR, Boyle IT (1977) Absent kidney sign associated with symmetrical and uniformly increased uptake of tracer by the skeleton. Eur J Nucl Med 2:257–260
Fon GT, Wong WS, Gold RH, Kaiser LR (1981) Skeletal metastases of melanoma. AJR 137:103–108
Francis MD, Fogelman I (1987) Tc99m diphosphonate uptake mechanism on bone. In: Fogelman I (ed) Bone scanning in clinical practice Springer Verlag, Berlin Heidelberg New York, pp 7–17
Freeman MH, Tonkin AK (1976) Manifestations of hypertrophic pulmonary osteoarthropathy in patients with carcinoma of the lung. Demonstration by 99mTc pyrophosphate bone scans. Radiology 120:363–365
Furnival CM, Blumgart LH, Citrin DL, McKillop JH, Fogelman I, Greig WR (1980) Serial scintiscanning in breast cancer: Indications and prognostic value. Clin Oncol 6:25–32.
Galasko CSB (1975) The significance of occult skeletal metastases, detected by scintigraphy, in patients with otherwise early breast cancer. Br J Surg 56:757–764
George MJ (1988) Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet 1:494–497
Gerber FH, Goodreau JJ, Kirchner PT, Fonty WJ (1977) Efficacy of preoperative and postoperative bone scanning in the management of breast carcinoma. N Engl J Med 297:300–303
Gilbert HB, Kagan AR (1976) Metastases: incidence, detection and evaluation. In: Weiss L (ed) Fundamental aspects of metastases. Elsevier, Amsterdam pp 385–405
Gillespie PJ, Alexander JL, Edelstyn GA (1975) Changes in 87mSr concentrations in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer. J Nucl Med 16:191–193
Goris ML, Bretille J (1985) Skeletal scintigraphy for the diagnosis of malignant metastatic disease to the bones. Radiother Oncol 3:319–329
Gravenstein S, Peltx MA, Poreis W (1979) How ominous is an abnormal scan in bronchogenic carcinoma? JAMA 241:2523–2524
Gray HW (1987) Soft tissue uptake of bone agents. In: Fogelman I (ed) Bone scanning in clinical practice. Springer-Verlag, Berlin Heidelberg New York, pp 211–235
Greenberg EJ, Chu FCH, Dwyer AJ, Ziminski EM, Dimisch AB Laughlin JS (1972) Effects of radiation therapy on bone lesions as measured by 47Ca and 85Sr local kinetics. J Nucl Med 13:747–751
Harbert JC, Rocha L, Smith FO, Delgado G (1982) The efficacy of radionuclide bone scans in the evaluation of gynecological cancers. Cancer 49:1040–1042
Hatfield DR, DeLand FH, Maruyama Y (1976) Skeletal metastases in pancreatic cancer: a study by isotope bone scanning. Oncology 33:44–47
Hayward JL, Carbone PP, Heuson JC, Kumoaka S, Sgaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13:89–94
Hayward SJ, Mclvor J, Burdge AH, Jewkes RF, Williams G (1987) Staging of prostatic cancer with radionuclide bone scintigraphy and lymphography. Br J Radiol 60:79–81
Hetherington JW, Siddall JK, Cooper EH (1988) Contribution of bone scintigraphy, prostatic acid phosphatase and prostatic specific antigen to the monitoring of prostatic cancer. Eur Urol 14:1–5
Hoefnagel CA, Delprat CC, Marcuse HR, de Viilder JJM (1986) Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 27:1854–1857
Hooper RG, Beechler CR, Johnson MC (1978) Radioisotope scanning in the initial staging of bronchogenic carcinoma. Am Rev Resp Dis 118:279–286
Howman-Giles RB, Gilday DL, Ash JM (1979) Radionuclide skeletal survey in neuroblastoma. Radiology 131:497–502
Huben RP, Schellhammer PF (1982) The role of routine follow up bone scans after definitive therapy of localised prostatic cancer. J Urol 128:510–512
Johnson DG, Coleman RE, McCook TA, Dale JK, Wells SA (1984) Bone and liver images in medullary carcinoma of the thyroid. J Nucl Med 25:419–422
Joo KG, Parthasarathy KL, Bakshi SP, Rosner D (1979) Bone scintigrams: Their clinical usefulness in patients with breast carcinoma. Oncology 36:94–98
Kamath CRV, Maruyama Y, De Land FH, van Nagell JR (1982) Value of bone scanning in detecting occult skeletal metastases from adenocarcinoma of the endometrium. Diagn Gynecol Obstet 4:155–158
Kamath CRV, Maruyama Y, De Land FH, van Nagell JR (1983) Role of bone scanning for evaluation of carcinoma of the cervix. Gynecol Oncol 15:171–185
Katz RD, Alderson PO, Rosenhein NB, Bowerman JW, Wagner HN Jr (1979) Utility of bone scanning in detecting occult metastases from cervical carcinoma. Radiology 133:469–472
Kelly RJ, Cason RJ, Ferrie CB (1979) Efficacy of radionuclide scanning in patients with lung cancer. JAMA 242:2855–2857
Khansur T, Haick A, Patel B, Balducci L, Vance R, Thigpen T (1987) Evaluation of bone scan as a screening work-up in primary and loco-regional recurrence of breast cancer. Am J Clin Oncol 10:167–170
Kies MS, Baker AW, Kennedy PS (1978) Radionuclide scans in staging of carcinoma of the lung. Surg Gynecol Obstet 147:175–176
Kim EE, Bledin AG, Gutierrez C, Haynie TP (1983) Comparison of radionuclide images and radiographs for skeletal metastases from renal cell carcinoma. Oncology 40:284–286
Kishi K, Horita T, Matsumoto K, Kakizoe T, Murase T, Fujita J (1981) Carcinoma of bladder: A clinical and pathological analysis of 87 autopsy cases. Urology 125:36–39
Kober B, Hermann HJ, Wetzel E (1979) “Cold lesions” in bone scintigraphy. Fortschr Rotgenstr 131:545–551
Koizumi K, Tonami N, Hisada K (1981) Diffusely increased Tc-99m MDP uptake in both kidneys. Clin Nucl Med 6:362–365
Komaki R, Cox, JD, Eisert RD (1977) Irradiation of bronchial carcinoma. II. Pattern of spread and potential for prophylactic irradiation. Int J Radiat Oncol Biol Phys 2:441–446
Komaki R, Donegan W, Manoli R, Teh EL (1979) Prognostic value of pretreatment bone scans in breast cancer. AJR 132:877–881
Kunkler IH, Merrick MV, Rodger A (1985) Bone scintigraphy in breast cancer: a nine year follow-up. Clin Radiol 36:279–282
Levenson RM, Sauerbrunn BJL, Bates HR, Newman RD, Eddy JL, Ihde DC (1983) Comparative value of bone scintigraphy and radiography in monitoring tumour response in systemically treated prostatic cancer. Radiology 146:513–518
Levenson RM, Saubrunn BJL, Ihde DE et al. (1981) Small cell cancer: radionuclide bone scans for assessment of tumour extent and response. AJR 137:31–35
Lindner A, Dekernion JB (1982) Cost effectiveness of pre cystectomy radioisotopic scans. J Urol 128:1181–1182
Lindholm A, Lundell L, Martenson B, Thulin A (1979) Skeletal scintigraphy in the initial assessment of women with breast cancer. Acta Chir Scand 145:513–518
Lopez-Majano V, Sobti P (1984) Early diagnosis of pulmonary osteoarthropathy in neoplastic disease. J Nucl Med Allied Sci 28:69–76
Lund F, Smith PH, Suciu S (1984) Do bone scans predict prognosis in prostatic cancer? Br J Urol 56:58–63
Marsoni S, Hurson S, Eisenberg M (1985) Chemotherapy of bone metastases. In: Garratini S (ed) Bone resorption, metastasis and diphosphonates. Raven Press, New York, pp 181–194
McGregor B, Tulloh AGS, Quinlan MF, Lovegrove F (1978) The role of bone scanning in the assessment of prostatic carcinoma. Br J Urol 50:178–181
McNeil BJ (1984) Value of bone scanning in malignant disease. Semin Nucl Med 14:277–286
McNeil BJ, Pace PD, Gray EB, Adelstein SJ, Wilson RE (1978) Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147:745–748
McNeil BJ, Polak JF (1981) An update on the rationale for the use of bone scans in selected metastatic and primary bone tumours. In: Pauwels EKJ, Schutte HE, Taconis WK (eds) Bone scintigraphy. Leiden University Press, Leiden, pp 187–208
Merrick MV (1987a) The normal bone scan. In: Fogelman I (ed) Bone scanning in clinical practice. Springer-Verlag, Berlin Heidelberg New York, pp 19–20
Merrick MV (1987b) Bone scintigraphy in testicular tumours. Br J Urol 60:167–169
Merrick MV (1989) Bone scintigraphy -an update. Clin Radiol 40:231–232
Merrick MV, Ding CL, Chisholm GD, Elton RD (1985) Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. Br J Urol 57:715–720
Merrick MV, Merrick JM (1986) Bone scintigraphy in lung cancer: a reappraisal. Br J Radiol 59:1185–1194
Mettler FA, Christie JH, Garcia JF, Baldwin MH, Wicks JD, Barstow SA (1981) Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma. Radiology 141:777–780
Moneypenny IJ, Grieve RJ, Howell A, Morrison JM (1984) The value of serial bone scanning in operable breast cancer. Br J Surg 71:466–468
Muss HB, Richards F, Barnes PL, Willand VV, Cowan R (1979) Radionuclide scanning in patients with advanced malignant melanoma. Clin Nucl Med 4:516–518
Narayam F, Lillian D, Hellstrom W, Hedgcock M, Jajodian PB, Tanagho EA (1988) The benefits of combining early radionuclide renal scintigraphy with routine bone scans in patients with prostatic cancer. J Urol 140:1448–1451
Nomura Y, Kondo H, Yamagata J et al. (1978) Evaluation of liver and bone scanning in patients with early breast cancer, based on results obtained from more advanced patients. Eur J Cancer 14:1129–1136
Nordman E, Marjamaki H, Tannila O (1977) The reliability of Tc99m pyrophosphate scintigraphy in the diagnosis of bony metastases. Ann Clin Res 9:31–34
Donoghue EP, Constable AR, Sherwood T, Stevenson JJ, Chisholm GD (1978) Bone scanning and plasma phosphatases in carcinoma of the prostate. Br J Urol 50:172–177
Operchal JA, Bowden RD, Grove RB (1976) Efficacy of radionuclide procedures in the staging of bronchogenic carcinoma. J Nucl Med 17:530 (abstract).
Padmanabhan N, Howell A, Rubens RD (1986) Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet 11:411–414
Parsarathy KL, Lansberg R, Bakshi SP, Donoghue G, Merrin C (1978) Detection of bone metastases in urological malignancies utilising 99mTc-labelled phosphate compound. Urology 11:99–102
Paulson DF and the Uro-Oncology Research Group (1979) The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. J Urol 121:300–302
Pauwels EKJ, Heslinga JM, Zwaveling A (1982) Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer. Clin Oncol 8:25–32
Perez DJ, Powles TJ, Milan J, Gazet JC, Ford HT, McCready VR, Macdonald JS, Coombs RC (1983) Detection of breast carcinoma metastases in bone: Relative merits of x-rays and skeletal scintigraphy. Lancet ii:613– 616
Podarsky AER, Stark DD, Hattner RS, Goodling GA, Moss AA (1983). Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumour localisation of 99mTc-MDP. AJR 141:469–472
Pollen JJ, Gerber K, Ashburn WL, Schmidt JD (1981) Nuclear bone imaging in metastatic cancer of the prostate. Cancer 47:1585–1594
Ouinn DL, Ostrow LB, Porter DK, Shelton DR, Jackson DE (1986) Staging of non small cell bronchogenic carcinoma. Relationship of clinical evaluation to organ scans. Chest 89:270–275
Ralston S, Fogelman I, Gardner MD, Boyle IT (1982) Hypercalcaemia and metastatic bone disease: is there a causal link? Lancet ii:903–905
Ramsdell JW, Peters RM, Taylor AT, Alazrak NP, Tisi GM (1977) Multiorgan scans for staging of lung cancer: correlation with clinical evaluation. J Thorac Cardiovasc Surg 73:653–659
Rappaport AH, Hoffer PB, Genant HK (1978) Unifocal bone findings by scintigraphy. Clinical significance in patients with known primary cancer. West Med 129:188–192
Reddy PS, Merrick MV (1983) Skeletal scintigraphy in carcinoma of the kidney. Br J Urol 55:171–173
Rosen PR, Murphy KG (1984) Bone scintigraphy in the initial staging of patients with renal cell carcinoma. J Nucl Med 25:289–291
Rosenthall L, Stern J, Arzoumanian A (1982) A clinical comparison of MDP and DMAD. Clin Nucl Med 7:403–406
Rossleigh MA, Lovegrove FTA, Reynolds PM et al. (1984) The assessment of response to therapy of bone metastases in breast cancer. Aust NZ J Med 14:19–22
Roth JA, Eilber FR, Bennett LR, Morton DL (1975) Radionuclide photoscanning. Usefulness in preoperative evaluation of melanoma. Arch Surg 110:1211–1212
Shafer RB, Reinke DB (1977) Contribution of the bone scan, serum acid and alkaline phosphatase and radiographic bone survey to the management of newly diagnosed carcinoma of the prostate. Clin Nucl Med 2:200–203
Shearer RJ, Constable AR, Girling M, Hendry WF, Fergusson JD (1974) Radiographic bone scintigraphy with the gamma camera in the investigation of prostatic cancer. Br Med J ii:362–365
Shih WJ, Purcell M, Domstad PA (1986) Evolving scintigraphic pattern of skeletal metastases from prostatic carcinoma. J Nucl Med 27:1786–1788
Sklaroff RB, Sklaroff DM (1976) Bone metastases from breast cancer at the time of radical mastectomy. Cancer 38:107–111
Smith FW, Gilday DL, Ash JM, Reid RH (1980) Primary neuroblastoma uptake of 99m-technetium methylene diphosphonate. Radiology 137:501–504
Smith ML, Martin W, McKillop JH, Fogelman I (1984) Improved lesion detection with dimethyl-amino-diphosphonate: A report of two cases. Eur J Nucl Med 9:519–520
Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd BN, Soloway S, Moinuddin M (1988) Stratification of patients with metastatic prostatic cancer based on extent of disease on initial bone scan. Cancer 61:195–202
Spencer GR, Khan M, Bird C, Seymour R, Brown TR, Collins CD (1981) Is bone scanning of value in patients with breast cancer? Acta Chir Scand 147:247–248
Sundkvist CMG, Ahlgren L, Lilja B, Mattson S, Abrahamson PA, Wadstrom LB (1988) Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy. Eur J Nucl Med 14:203–206
Sven NR, Karstens JH, Gloeckner W, Steinstrasser A, Schwarz A, Ammon J, Buell U (1989) Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet i:299– 301
Terry DW, Isitman AI, Holmes RA (1975) Radionuclide bone images in hypertrophic pulmonary osteoarthropathy. AJR 124:571–576
Thomas JH, Panoussopoulus D, Liesmann GE, Jewell WR, Preston DF (1979) Scintiscans in the evaluation of patients with malignant melanoma. Surg Gynecol Obstet 149:574–576
Thomsen HS, Rasmussen D, Munck O, Lund JO, Gerhard-Nielsen V, Terkildsen T, Domber-nowsky P, Andersen KW (1987). Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy. Eur J Cancer Clin Oncol 23:779–781
Turner P, Haggith JW (1981) Preoperative radionuclide scanning in bronchogenic carcinoma. Br J Dis Chest 75:291–294
Vest SA (1954) Prostatic malignancy. Clin Symp 6:93–103
Vider M, Maruyama Y, Narvaez R (1977) Significance of the vertebral venous (Batson’s) plexus in metastatic spread in colorectal cancer. Cancer 40:67–71
Wahner HW, Kyle RA, Beabout JW (1980) Scintigraphic evaluation of the skeleton in multiple myeloma. Mayo Clin Proc 55:739–746
Waxman AD, Siensen JK, Levine AM (1981) Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy. J Nucl Med 22:232–236
Wickerham L, Fisher B, Cronin W, members of the NSABP Committee for treatment failure. (1984) The efficacy of bone scanning in the follow-up of patients with operable breast cancer. Breast Cancer Res Treat 4:303–307
Wilkinson MJS, Howell A, Harris M, Adam NM, Lupton E, Johnson RJ, Seilwood RA (1985) Retroperitoneal tumour infiltration detected by bone scanning in patients with infiltrating lobular carcinoma of the breast. Br J Surg 72:626–628
Wolfe JA, Rowe LD, Lowry LD (1979) Value of radionuclide scanning in the staging of head and neck carcinoma. Ann Otol Rhinol Laryngol 88:832–836
Wolfenden JM, Pitt MJ, Durie BGW, Moon TE (1980) Comparison of bone scintigraphy and radiology in multiple myeloma. Radiology 134:723–728
Yeates MG, Tan PKS, Broadfoot E, Green D, Morris JG (1972) Bone scanning with technetium polyphosphate. Preliminary results. Australas Radiol 16:393–400
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag London Limited
About this chapter
Cite this chapter
Fogelman, I., McKillop, J.H. (1991). The Bone Scan in Metastatic Disease. In: Rubens, R.D., Fogelman, I. (eds) Bone Metastases. Springer, London. https://doi.org/10.1007/978-1-4471-3254-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3254-7_3
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3256-1
Online ISBN: 978-1-4471-3254-7
eBook Packages: Springer Book Archive